HSK16149

oral, brain-penetrant VGCC inhibitor

Ph. II/III for diabetic neuropathic pain in China

gabapentenoid

J. Pharmacol. Exp. Ther., Mar. 1, 2021

Haisco Pharmaceutical, Chengdu, CN

10. The Haisco voltage-gated calcium channel (VGCC) alpha-2-delta subunit inhibitor, HSK16149, is a potent and potentially longer-acting gabapentinoid drug candidate for chronic pain over pregabalin, with a potentially wider…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks